630 related articles for article (PubMed ID: 24216286)
1. Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine.
Sala-Farré MR; Arias-Varela C; Recasens-Recasens A; Simó-Sanahuja M; Muñoz-Almagro C; Pérez-Jové J
Enferm Infecc Microbiol Clin; 2015 Jan; 33(1):27-31. PubMed ID: 24216286
[TBL] [Abstract][Full Text] [Related]
2. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
3. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
Matter HC; Schmidt-Schläpfer G; Zimmermann H
Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704
[TBL] [Abstract][Full Text] [Related]
4. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].
Campins M; Moreno-Pérez D; Gil-de Miguel A; González-Romo F; Moraga-Llop FA; Arístegui-Fernández J; Goncé-Mellgren A; Bayas JM; Salleras-Sanmartí L
Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):240-53. PubMed ID: 23411362
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of acellular pertussis vaccination during childhood (<7 years of age) for preventing pertussis in household contacts 1-9 years old in Catalonia and Navarra (Spain).
Plans P; Toledo D; Sala MR; Camps N; Villanova M; Rodríguez R; Alvarez J; Solano R; García-Cenoz M; Barrabeig I; Godoy P; Minguell S
Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):2059-2067. PubMed ID: 27612470
[TBL] [Abstract][Full Text] [Related]
6. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.
Witt MA; Katz PH; Witt DJ
Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127
[TBL] [Abstract][Full Text] [Related]
7. [Acellular vaccines (DTPa/dTpa) against whooping cough, protection duration].
Rigo-Medrano MV; Mendoza-García JL; Gimeno-Gascón A; Roda-Ramón J; Cremades-Bernabeú I; Antequera-Rodríguez P; Alcalá-Minagorre PJ; Ortiz-de la Tabla V; Rodríguez-Díaz JC
Enferm Infecc Microbiol Clin; 2016 Jan; 34(1):23-8. PubMed ID: 25735715
[TBL] [Abstract][Full Text] [Related]
8. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.
Misegades LK; Winter K; Harriman K; Talarico J; Messonnier NE; Clark TA; Martin SW
JAMA; 2012 Nov; 308(20):2126-32. PubMed ID: 23188029
[TBL] [Abstract][Full Text] [Related]
9. Increase of pertussis cases in the Vallès region, Catalonia, Spain, September 2023 to April 2024.
Poltorak V; Cabré-Riera A; Martínez-Botías F; Borràs López E; Clotet Romero L; Sala Farré MR; Jané Checa M;
Euro Surveill; 2024 Jun; 29(24):. PubMed ID: 38873794
[TBL] [Abstract][Full Text] [Related]
10. California pertussis epidemic, 2010.
Winter K; Harriman K; Zipprich J; Schechter R; Talarico J; Watt J; Chavez G
J Pediatr; 2012 Dec; 161(6):1091-6. PubMed ID: 22819634
[TBL] [Abstract][Full Text] [Related]
11. Pertussis in infants under one year old: risk markers and vaccination status--a case-control study.
Zamir CS; Dahan DB; Shoob H
Vaccine; 2015 Apr; 33(17):2073-8. PubMed ID: 25728322
[TBL] [Abstract][Full Text] [Related]
12. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780
[TBL] [Abstract][Full Text] [Related]
13. Association between pertussis vaccination coverage and other sociodemographic factors and pertussis incidence using surveillance data.
Rane MS; Wakefield J; Rohani P; Halloran ME
Epidemics; 2023 Sep; 44():100689. PubMed ID: 37295130
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of pertussis outbreaks in Catalonia, Spain, 1997 to 2010.
Crespo I; Broner S; Soldevila N; Martínez A; Godoy P; Sala-Farré MR; Company M; Rius C; Domínguez A; Group Of Catalonia TP
Hum Vaccin Immunother; 2015; 11(1):231-5. PubMed ID: 25483541
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
Gustafsson L; Hessel L; Storsaeter J; Olin P
Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
[TBL] [Abstract][Full Text] [Related]
16. Pertussis vaccination for adolescents and adults.
Franco E; Giambi C; Ialacci R; Maurici M
Expert Opin Biol Ther; 2004 Oct; 4(10):1669-76. PubMed ID: 15461578
[TBL] [Abstract][Full Text] [Related]
17. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
18. Pertussis epidemic--Washington, 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jul; 61(28):517-22. PubMed ID: 22810264
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of acellular pertussis vaccine in young infants.
Aoyama T; Iwata T; Iwai H; Murase Y; Saito T; Akamatsu T
J Infect Dis; 1993 Feb; 167(2):483-6. PubMed ID: 8421187
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of acellular pertussis vaccine and evolution of pertussis incidence in the community of Madrid from 1998 to 2015.
Latasa P; García-Comas L; Gil de Miguel A; Barranco MD; Rodero I; Sanz JC; Ordobás M; Arce A; Garrido-Estepa M
Vaccine; 2018 Mar; 36(12):1643-1649. PubMed ID: 29439872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]